Advil-maker Haleon boosts sales by targeting consumers on weight-loss drugs
Summary
Haleon is increasing sales by marketing products that address side effects associated with GLP-1 weight-loss drugs, including through targeted placement in stores.
The GLP-1 market is creating a new demand channel for over-the-counter remedies, and Haleon is
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
GLP-1 adoption is reshaping demand beyond pharmaceuticals, creating new growth opportunities for consumer-health brands.